Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
OTC Markets
14:24:12 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 6.000 USD | -0.41% |
|
-6.10% | -2.45% |
| Market Cap | 33.25M 29.69M 27.7M 25.16M 47.35M 3.22B 47.81M 333M 130M 1.64B 125M 122M 5.26B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 31.93M 28.51M 26.6M 24.16M 45.47M 3.09B 45.91M 319M 125M 1.57B 120M 117M 5.05B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IDXG | Delayed | |
Börse Stuttgart
| PF4 | Delayed | |
|
Boerse Muenchen
| PF4 | Real-time |
| 1 day | -0.41% | ||
| 1 week | -6.10% | ||
| Current month | -6.10% | ||
| 1 month | -13.20% | ||
| 3 months | -26.15% | ||
| 6 months | -39.47% | ||
| Current year | -2.45% |
| 1 week | 6 |  | 6.32 |
| 1 month | 5.97 | | 6.65 |
| Current year | 5.15 | | 12 |
| 1 year | 4.03 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 48.5 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Free | Director | 69,252 | 0.2501% | ||
| 8/20/26 | Exercice | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 8/20/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -6.10% | +36.65% | +25.65% | 33.25M | |
| -0.17% | +3.05% | +14.13% | +25.61% | 112B | |
| +1.33% | +5.11% | +4.40% | +81.36% | 96.35B | |
| -1.21% | -4.33% | +127.08% | +797.34% | 56.33B | |
| +0.55% | -5.05% | -12.46% | +48.17% | 26.23B | |
| +0.71% | +3.15% | +13.22% | +56.02% | 25.48B | |
| +1.65% | -0.12% | +27.60% | +85.73% | 25.48B | |
| +0.26% | +1.55% | -16.65% | -2.43% | 21.32B | |
| +0.28% | +2.60% | +29.97% | +322.59% | 20.98B | |
| +2.61% | +18.47% | +11.12% | +87.91% | 19.83B | |
| Average | +0.56% | +1.86% | +23.51% | +152.79% | 40.43B | |
| Weighted average by Cap. | +0.44% | +2.47% | +25.67% | +170.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.9M 39.09M 35.51M 66.82M 4.54B 67.47M 469M 184M 2.31B 176M 172M 7.43B | 38.73M 34.58M 32.26M 29.31M 55.15M 3.75B 55.69M 387M 152M 1.91B 145M 142M 6.13B |
| Net income | 6.7M 5.98M 5.58M 5.07M 9.54M 649M 9.64M 67.03M 26.22M 330M 25.16M 24.62M 1.06B | 24.58M 21.95M 20.47M 18.6M 35M 2.38B 35.34M 246M 96.14M 1.21B 92.27M 90.27M 3.89B |
| Net Debt | 4.4M 3.92M 3.66M 3.33M 6.26M 426M 6.32M 43.96M 17.19M 216M 16.5M 16.14M 696M | -1.32M -1.18M -1.1M -1M -1.88M -128M -1.9M -13.22M -5.17M -65.06M -4.96M -4.86M -209M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | US$6.000 | -0.41% | 354 |
| 26-10-02 | US$6.025 | -5.71% | 765 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
